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Abstract
The structure of BPSL1549, a protein of unknown function from Burkholderia pseudomallei
reveals a similarity to E. coli cytotoxic necrotizing factor 1. We found that BPSL1549 acted as a
potent cytotoxin against eukaryotic cells and was lethal when administered to mice. Expression
levels of bpsl1549 correlate with conditions expected to promote or suppress pathogenicity.
BPSL1549 promotes deamidation of Gln339 of the translation initiation factor eIF4A, abolishing
its helicase activity and inhibiting translation. We propose to name BPSL1549 Burkholderia
Lethal Factor 1 (BLF1).
The bacterium Burkholderia pseudomallei is the causative agent of melioidosis (1) and, in
endemic areas including Southeast Asia, can be isolated from moist soil and stagnant water.
B. pseudomallei infects many tissue, causing subclinical infections, acute septicaemia and
sub-acute and chronic disease. The pathogen has the ability to remain latent in a host for
decades (2) and infections in troops serving in endemic areas has resulted in the pathogen
being referred to by the nickname, the “Vietnam Time Bomb” (3). There is no vaccine and
the organism is multidrug resistant complicating treatment. The molecular mechanisms that
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underlie disease are largely unknown. To address this, a programme of structure
determination on proteins of unknown function from B. pseudomallei has been initiated.
The structure of BPSL1549, a 23 kDa protein of unknown function, was determined at 1.04
Å resolution (Table S1, Fig. S1A). The fold consists of a sandwich of two curved mixed beta
sheets decorated on the outside by alpha helices and loops (Fig 1A) and was similar to the
catalytic domain of E. coli cytotoxic necrotizing factor 1 (CNF1-C) (4). Eleven strands of
the BPSL1549 beta sandwich have identical sequence order and direction to those of CNF1-
C, with an rmsd of 3.9 Å for 170 superposed ͣ-carbon atoms (Fig. 1B). However, on the
peripheries of the structures there are differences in both the extensions to the ͤ-strands and
the helices and loops, with only one helix in common.
CNF1-C inactivates Rho GTPases by deamidation of a glutamine necessary for GTPase
hydrolysis, thereby affecting actin cytoskeleton assembly (5). CNF1-C and BPSL1549
showed virtually no sequence identity, except at the active sites where the LSGC motif of
CNF1-C was conserved in BPSL1549 (Fig. S1B,C). The cysteine of this motif, Cys866/
Cys94 in CNF1-C and BPSL1549, respectively, is the crucial nucleophile in the CNF1-C
catalytic triad responsible for deamidase activity (4). His881, the second component of the
CNF1-C triad was present in BPSL1549 (as His106) and superposed well (Fig. 1C). In
CNF1-C the third component of the triad is a main chain carbonyl, but in BPSL1549 the
OG1 of Thr88 hydrogen bonds to the histidine. A structurally conserved tyrosine (Tyr164 in
BPSL1549, Tyr962 in CNF1-C) hydrogen bonds to the main chain carbonyl of the catalytic
cysteine (Fig. 1C).
The conservation of key catalytic residues with CNF1-C, suggested BPSL1549 was a
glutamine deamidase. However, the molecular surface around the BPSL1549 active site
cavity was broader and shallower than that of CNF1-C suggesting the deamidation target
was different (Fig S2). Nevertheless, the structure implied that, like CNF1-C, BPSL1549
might be cytotoxic. Intraperitoneal injection of Balb/C mice with BPSL1549 was lethal by
day 14 (Supplementary online material). BPSL1549 was also toxic to J774 macrophage cells
within 3 days (Fig. 2A). In contrast, growth of 3T3 cells was insensitive to BPSL1549
unless the protein delivery reagent BioPORTER was included (Fig. S3A). The differential
sensitivity between macrophages and fibroblasts may reflect uptake by active
macropinocytosis in macrophages, although how the toxin accesses the cytoplasm is unclear.
On the basis of the abolition of the biological activity of CNF1 when Cys866 is mutated to
serine, a BPSL1549C94S mutant was created. In mice BPSL1549C94S was non-toxic,
whereas in J774 cells some toxicity (p < 0.05) was observed, but only at the highest toxin
concentration tested (Fig 2A). Thermal stability studies (Fig. S3B,C) together with the
BPSL1549C94S structure (Table S1) confirmed that this point mutation does not disrupt the
structure and that C94 is required for BPSL1549 activity.
To investigate a role for bpsl1549 in bacterial virulence, an in-frame deletion mutant of
bpsl1549 in B. pseudomallei was constructed. Whilst we cannot exclude the influence of
polarity effects in the ͇bpsl1549 strain, compared to the wild type strain the mutant was
significantly attenuated when mice were challenged by the i.p. route (Fig. 2B). The median
lethal dose of B. pseudomallei ͇bpsl1549 was 1.26 × 105 colony forming units (CFU), 100
times higher than that for the wild type B. pseudomallei strain K96243, consistent with a
role for bpsl1549 in virulence. Moreover, bpsl1549 expression was highly upregulated in
response to multiple virulence cues (Fig. S4).
An affinity column was used to purify BPSL1549 binding-partners from human cell extract.
The major protein purified was translation initiation factor eIF4A which was confirmed by
immunoblotting (Fig. 3A). Interaction with endogenous eIF4A was verified by
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coimmunoprecipitation with FLAG-BPSL1549. FLAG-BPSL1549C94S precipitated more
eIF4A than FLAG-BPSL1549, suggesting that release of the substrate from the toxin
requires completion of deamidation (Fig. 3B).
The BPSL1549:eIF4A interaction suggested BPSL1549 might inhibit translation and its
expression in human cells led to 90% or greater reduction in gene expression for two
reporters. Reduced translation inhibition by BPSL1549C94S may result from binding eIF4A
(Fig. 3B,C). The reporter mRNA levels were unaffected, consistent with BPSL1549
blocking translation (Fig. 3C, right panel). BPSL1549 reduced endogenous protein synthesis
monitored by 35S-Met/Cys incorporation at levels similar to that seen with the eIF4A
inhibitor hippuristanol (6), whereas BPSL1549C94S did not (Fig. 3D). The ongoing
translation in the presence of BPSL1549 may arise from eIF4A-independent mRNAs. To
assess the impact of BPSL1549 on translation initiation we monitored the abundance of
ribosomal subunits, monosomes and polysomes in cell extracts (Fig. 3E). BPSL1549
enhanced the size of the 80S peak and reduced the size of the polysome peaks with polyA
binding protein (PABP) being absent in this region of the gradient. This suggested
translation initiation was stalled, mirroring the situation seen with the eIF4A specific
inhibitor pateamine A (7).
A translational block can trigger cytoplasmic stress granule formation either by an eIF2ͣ
phosphorylation-dependent or independent pathways induced by cellular stresses or by
inactivation of eIF4A, 4G, 4B,4H or PABP respectively (8). Sodium arsenate treatment led
to both stress granule formation and eIF2ͣ phosphorylation (Fig. S5). BPSL1549 expression
also caused stress granule formation, but not eIF2ͣ phosphorylation, consistent with
activation of the eIF2ͣ phosphorylation-independent pathway. BPSL1549C94S failed to
trigger stress granule formation efficiently, consistent with its reduced ability to inhibit
translation. .
To identify the modification in eIF4A we used MS to analyse FLAG-eIF4AI purified from
human cells expressing BPSL1549 (Fig. S6). MS revealed deamidation of Gln339 to Glu
(Fig. 4A). Gln339 is in the C-terminal domain of eIF4A and is the first glutamine of a
conserved Gln-Gln pair lying between motifs V and VI (9). This loop is adjacent to the cleft
between the enzyme’s two domains and lies between the ATP and RNA binding sites (Fig
S7) suggesting modification might inhibit eIF4A ATPase or helicase activities. In vitro,
BPSL1549 deamidates eIF4A Gln339 with a turnover number of ~700 per minute, similar to
the rate of depurination catalysed by ricin (10) (Fig. S8, S9). Consistent with Gln339 being
the target residue, BPSL1549 binds less efficiently to eIF4AIQ339E, the product of the
deamidation reaction (Fig. S10). Two isoforms of eIF4A (I and II) have a glutamine at
position 339, whereas eIF4AIII, an exon junction complex subunit, has proline at this
position and is unlikely to be a BPSL1549 substrate.
Expression of eIF4AI Q339E in vivo reduced expression of two reporters, indicating Q339E
is dominant negative, whereas control mutation Q340E had no effect (Fig. 4B). Q339E had
no effect on eIF4A1 ATPase activity or RNA and ATP binding (Fig. S11). However, Q339E
reduced RNA helicase activity (Fig. 4C). eIF4AI mutations that uncouple the ATPase and
helicase activities are known to act as inhibitors of translation (11). At molar ratios of 1:500
BPSL1549:eIF4A there was 47% inhibition of helicase activity indicative of enzymatic
modification by BPSL1549. Whereas BPSL1549C94S only caused 15% inhibition of
helicase activity at a molar ratio of 1:10 BPSL1549C94S:eIF4A, probably caused by
BPSL1549C94S binding to eIF4A (Fig S12). Based on the closed conformation structure of
eIF4AIII (12), Gln339 in eIF4AI would lie close to Asp337 and Arg368 and the 3ᓉ adenine
ribose hydroxyl of ATP (Fig. S13). Thus, deamidation of Gln339 probably disrupts
interaction between these residues, influencing the functions of Asp337. In the Vasa RNA
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helicase, the structural equivalent of eIF4AI Asp337 is Asp534 and a D534A mutation
uncouples ATP hydrolysis and RNA binding from the helicase activity (13).
We examined the impact of BPSL1549 on formation of the cap binding complex eIF4F.
BPSL1549 had no impact on the levels of eIF4E, 4G1 or PABP bound, but increased the
amount of eIF4A recovered (Fig. 4D), suggesting eIF4A was more stably bound within
eIF4F. Endogenous eIF4A was readily exchanged with recombinant eIF4A within eiF4F
when cell extracts were pre-incubated with the control splicing factor SC35 (Fig. 4E lanes
6,7) but in cell extracts pre-incubated with BPSL1549, recombinant eIF4A did not
efficiently displace endogenous eiF4A from eIF4F. Thus recycling of eIF4A, required for
efficient translation (11),(14) would be impaired.
Compared to CNF1-C a major difference with BPSL1549 is the lack of the receptor binding
and translocation domains, essential for cytoplasmic delivery of CNF1-C. However, the
intracytoplasmic lifestyle of B. pseudomallei removes the need for BPSL1549 to cross the
eukaryotic cell membrane, though the absence of an obvious BPSL1549 signal sequence
leaves its mechanism of secretion uncertain. The demonstration that BPSL1549 is a potent
inhibitor of translation suggests that it is an important weapon in the armoury of B.
pseudomallei and we suggest renaming it Burkholderia Lethal Factor 1 (BLF1). The
identification of structurally unrelated papain-like glutamine deamidases CHBP in B.
pseudomallei (15) and PMT in Pasteurella multocida (16) suggests this type of chemistry
may be more generally employed by pathogenic bacteria than is currently recognised.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Structural analysis of BPSL1549
(A) Cartoon representation of BPSL1549 with helices and strands numbered. (B) Cartoon
representation showing the similarity in overall fold between BPSL1549 (blue) and CNF1-C
(red). (C) Detail of superposition of BPSL1549 (pale blue) and CNF1-C (pale red) around
their active sites with residues strongly conserved between the two toxins, including the
critical cysteine and histidine, highlighted. Hydrogen bonds shown as dotted lines.
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Fig. 2. Toxic effects of BPSL1549
(A)Effect of BPSL1549 and C94S mutant on the BALB/c J774.2 macrophage cell line after
72h. Values correspond to the means of three to seven independent experiments performed
in duplicate and error bars represent S.D. Data were analysed by ANOVA and values
significantly different from control (no toxin) are shown as *** p < 0.0001; * p < 0.05.
Significant toxic effects were evident at concentrations down to 2.5 × 10−7 M (5.7 ͮg.ml−1)
with an EC50 of 2.7 × 10−7 M (6.2 ͮg.ml−1). (B) Survival of BALB/c mice (n=6) challenged
with 4.2 × 104 cfu/ml B. pseudomallei K96243 (•) or 5.8 × 104 cfu/ml B. pseudomallei
K96243͇BPSL1549 (ᦔ) (p<0.001).
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Fig. 3. BPSL1549 modifies eIF4A and blocks translation
(A) SDS-PAGE analysis of human proteins eluted from a 6xHisBPSL1549 affinity column
using NaCl elution buffer. The control protein was 6xHis YloQ (GTPase from B.subtilis).
The major band was identified by mass spectrometry (MS) as eIF4A and confirmed by
immunoblotting (lower panel). (B) Co-immunoprecipitation of FLAG-BPSL1549 or FLAG-
BPSL1549C94S using FLAG antibody with endogenous eIF4A. FLAG-BAP (bacterial
alkaline phosphatase) was used as a control. (C) Reporter gene assays 24 hours post-
transfection with FLAG-BPSL1549 or FLAG-BPSL1549C94S. Enzyme assays (left panel)
and qRT-PCR analysis of reporter mRNA levels (right panel). RT = reverse transcriptase.
(D) 35S-Met/Cys incorporation into proteins in 293T cells following transfection with
control FLAG-BAP, FLAG-BPSL1549 or FLAG-BPSL1549C94S. (E) Polysome analysis
of 293T cell extracts from cells transfected with FLAG or FLAG-BPSL1549 vectors. The
lower panels show immunoblots of fractions with a PABP antibody. Error bars represent the
S.D. from three independent experiments.
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Fig. 4. BPSL1549 inhibits eIF4AI RNA helicase activity
(A) Tandem MS analysis of the deamidated peptide GIDVEQVSLVINYDLPTNR [M
+2H] 2+ from eIF4A. The prominent b and y ions are highlighted. Inset shows an expanded
view of the intact mass of the [M+2H] 2+ peptide (B) Reporter genes were cotransfected
with wild type or Q339E eIF4AI and enzyme activities measured. FLAG-eIF4AI construct
expression was confirmed by immunoblotting (lower panel). Error bars represent S.D. from
three independent experiments. (C) RNA helicase assays with eIF4AI and mutants (upper
panel); the lower panel shows quantification from 3 separate helicase assays with S.D.
shown by error bars. Helicase activity in % = (ssRNA)/(dsRNA + ssRNA)*100. eIF4B
stimulates the helicase activity of eIF4AI. UAP56 is a control RNA helicase and Magoh, a
component of the exon junction complex, is a non RNA binding control. (D) Purification of
eIF4F using methyl-7 GTP sepharose and Protein G sepharose as control. eIF4F components
were identified by immunoblotting. (E) eIF4AI recycling assay. eIF4F was purified from
extracts treated with BPSL1549 or SC35 (control) as indicated. Following purification,
recombinant eIF4AI was added to eIF4F bound to methyl-7 GTP sepharose. Proteins were
identified by immunoblotting. WCE = whole cell extract.
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